ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
2 hedge funds and large institutions have $6K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 16 closing their positions.
89% less funds holding
Funds holding: 18 → 2 (-16)
99% less capital invested
Capital invested by funds: $813K → $6K (-$807K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$283 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$327K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$249K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$68K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$43K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$42K |
ECTE Hedge Fund Activity: Q3 2016 in Review
2 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q3 2016, worth a combined $6K — down 99% from $813K a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ECTE and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Acrospire Investment Management, adding an estimated $283. The largest seller was Vanguard Group, exiting entirely with an estimated $327K sold.
- 2 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q3 2016, down from 18 in Q2 2016.
- Funds reported $6K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q3 2016, down 99% quarter-over-quarter.
- 0 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q3 2016 and 16 closed out, a net change of -16 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q3 2016 was Acrospire Investment Management, an estimated $283 added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q3 2016 was Vanguard Group, an estimated $327K sold.
Based on aggregated 13F filings for Q3 2016.